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Original Article
Psychiatric Morbidity in HIV-infected 
Male Prisoners
Eugene Yu-Chang Peng,1,2 Ming-Been Lee,3 Donald Edward Morisky,4 Ching-Ying Yeh,2
David Farabee,5 Yu-Ching Lan,6,7 Yi-Ming Arthur Chen,7 Shu-Yu Lyu2,7*
Background/Purpose: The seroincidence of human immunodeficiency virus (HIV) in Taiwan has drasti-
cally increased since 2004, particularly among injection drug users and prisoners. The major purpose of
this study was to explore the prevalence and correlates of psychiatric morbidity among HIV-infected male
prisoners.
Methods: In 2006, data were collected from all of HIV-infected male prisoners (n = 535) in seven prisons
in Taiwan. This collection was performed using a self-administered, anonymous questionnaire in group
settings directed by our interviewers. Psychiatric morbidity was measured using the five-item Brief
Symptom Rating Scale in 535 participants, which represented an 85% response rate. After excluding 
incomplete data, 479 participants were included in the analysis.
Results: Psychiatric morbidity was present in 46% of participants. Multivariate logistic regression revealed
that correlates of the five-item Brief Symptom Rating Scale defined cases included the following: being a
recidivist, having poor self-rated health status, and having experienced psychiatric symptoms in one’s life-
time (e.g. significant physical pain or discomfort, depression for 2 weeks or longer, serious anxiety or ten-
sion, trouble understanding, concentrating, or remembering, and serious thoughts of suicide), with a
Nagelkerke R2 equal to 0.365.
Conclusion: Psychiatric morbidity is prevalent among HIV-infected male prisoners. Tailored HIV/AIDS 
education related to mental health is therefore suggested for inclusion as part of a comprehensive HIV/AIDS
training program among incarcerated populations.
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Human immunodeficiency virus (HIV)-infected
patients have higher rates of psychiatric morbidity
compared with the general population.1−4 Pre-
vious studies have shown that approximately
20–52% of people with HIV were identified as
suffering from one or more than one psychiatric
disorders,4−6 which is approximately 2–3 times
higher than the prevalence found in the general
population.7
There is evidence that mental illness compli-
cates the HIV epidemic. Psychiatric morbidities
increase the risk of contracting HIV, and are associ-
ated with decreased highly active antiretroviral
therapy utilization, adherence, and virological
suppression.8 Without effective recognition and
treatment of mental disorders, HIV treatment out-
comes can be expected to decline, and the rates
of disease transmission continue unabated.9 Fur-
thermore, a lack of psychiatric morbidity in HIV-
positive individuals is a significant factor for a
better quality of life.10,11
Consistent findings of co-morbidity between
psychiatric disorders and HIV infection in correc-
tional settings have also been reported.12−16 Factors
contributing to increased prevalence of psychiatric
morbidities among HIV seropositive individuals
are a lack of family or social support and intra-
venous drug use.11 Greater attention should be
given to HIV-infected inmates with mental health
problems. However, since low educational status
is common among incarcerated populations, an
appropriate short screening instrument needs to
be selected to identify psychiatric morbidity.
The seroincidence of HIV in Taiwan has dras-
tically increased since 2004, particularly among
injection drug users and prisoners.17,18 Since 1988,
all HIV/AIDS cases in Taiwan have received free
medical treatment and highly active antiretro-
viral therapy was introduced in 1997. Insufficient
attention, however, was paid to co-existing mental
disorders and HIV infection within the incarcer-
ated population. This study aimed to explore the
prevalence and contributing factors of psychiatric
morbidity among HIV-seropositive adult male
prisoners in Taiwan.
Materials and Methods
Data collection
Settings and sampling procedures
There are 24 prisons in Taiwan. All prisons were
sorted into the Northern, Central, Southern, and
Eastern areas. We selected one or two prisons in
each area according to prison size. The chosen
prisons represented the variety of inmates in that
geographic area. A total of seven prisons were 
selected.
The HIV seropositive status of all inmates is
identified by mandatory (as required by law)
HIV blood testing upon incarceration. Prisoners
identified as being HIV-positive are subsequently
separated from the HIV-negative prison pop-
ulation. This separation enabled us to identify
the potentially eligible participants. This cross-
sectional study was conducted between October
and November, 2006.
Subjects
All HIV-infected male prisoners in the seven cho-
sen prisons were invited to participate in this study.
The survey involved a self-administered anony-
mous questionnaire; including a five-item Brief
Symptom Rating Scale (BSRS-5) conducted in a
group setting directed by our interviewers.
A total of 633 HIV-infected adult male pris-
oners were identified in the chosen prisons dur-
ing the study period, of which 535 completed
the questionnaire, resulting in a response rate of
84.5%. After excluding forms with incomplete data
for the BSRS-5, i.e. those who did not answer all
five items of the BSRS-5, 479 participants were
included in the analysis.
Measures
Participants’ characteristics
Participants’ major demographic characteristics in-
cluded age, years of education, and marital status.
Other selected characteristics included current
crime type, prior recidivism, illicit drug use history,
self-rated health status, and year of notification
of HIV infection.
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Psychiatric morbidity
The participants’ psychiatric morbidity was mea-
sured by the BSRS-5, which contained five symp-
tom items selected from the 50-item BSRS, namely
feeling tense or “keyed up”, feeling blue, feeling
easily annoyed or irritated, feeling inferior to oth-
ers, and having trouble falling asleep. The BSRS-5
measure has good internal consistency, with
Cronbach’s α ranging from 0.77 to 0.90.19 Further-
more, these items have been shown to correlate
highly with the five dimensions in the 50-item
BSRS, namely anxiety, depression, hostility, inter-
personal hypersensitivity/sleep disturbance, and
additional symptoms/inferiority. Correlations
between the BSRS-5 and the dimensions in 50-
item BSRS ranged from 0.76 to 0.85.19 In previous
studies, the BSRS-5 has been extensively used as a
short screening tool to identify common psychi-
atric morbidity19,20 as well as suicide ideation21
in clinical cases and community residents.
Participants in the present study were asked
to indicate how much discomfort they had expe-
rienced in each of the five domains during the past
week, using a five-point Likert-type scale: “Not at
all” (score 0); “A little bit” (score 1); “Moderately”
(score 2); “Quite a bit” (score 3); and “Extremely”
(score 4). Total BSRS-5 scores ranged from 0 to
20, with a cut-off score of 6 or above considered
to be “psychiatric cases”.19
To examine whether a single factor could be
extracted from the data, we conducted a princi-
pal components analysis on the BSRS-5 items. The
identified factor accounted for about 74.5% of
the variance. The BSRS-5 also showed good inter-
nal consistency in the present sample (α = 0.91).
Psychological status
Based on lifetime experience, the participants were
asked to indicate whether they had ever experi-
enced the following: (1) a lot of physical pain or
discomfort; (2) serious depression (for ≥ 2 weeks
at a time); (3) serious anxiety or tension; (4) hal-
lucinations (hearing or seeing things that others
thought were imaginary); (5) trouble understand-
ing, concentrating, or remembering; (6) trouble
controlling violent behavior; (7) serious thoughts
of suicide; and (8) attempts at suicide. 
These questions were modified from the
“Initial assessment” developed by researchers at
the Texas Christian University.22 These items have
been shown to correlate well with more formal
diagnostic measures of psychiatric disorders.22 The
internal consistency of the psychological status
in this study sample is acceptable (α = 0.59).
Statistical analyses
Data were analyzed using SPSS version 14.0 (SPSS
Inc., Chicago, IL, USA). Reliability tests and factor
analysis were used to check internal consistency
and validity of the BSRS-5. Univariate analysis,
independent t test, Fisher’s exact test, and χ2 test
were applied for between-group comparisons
where appropriate. The prevalence of each item
from the BSRS-5 was indicated by combining 
the percentage of “Quite a bit” and “Extremely”
responses, i.e. BSRS-5 ≥ 3.
Using a cut-off score of 6 or above as the BSRS-
defined case group, bivariate analysis was em-
ployed to examine the difference and associated
factors between case and non-case groups. Those
variables with significant differences in bivari-
ate analyses were all included in the multivariate
analyses. A multiple logistic regression was car-
ried out to identify risk factors for BSRS-5 de-
fined cases. Odds ratios (ORs) were presented as
estimates for the strength of associations. A p
value of less than 0.05 was considered statistically
significant.
Results
Characteristics of participants
According to Table 1, the average age was 34.2± 7.6
years, ranging from 19 to 60 years of age. A total of
51.6% of the participants were junior high school
graduates, and 13.8% were married or living with
someone prior to incarceration.
Participants with BSRS-5 scores ≥ 6 were sig-
nificantly more likely to be recidivists, to have
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Table 1. Participants’ characteristics by Brief Symptom Rating Scale-5 score (n = 479)*
Variable
BSRS-5 score
Total p
< 6 ≥ 6
Education level†
Elementary school or under 37 (14.5) 34 (15.4) 71 (14.9) 0.200
Junior high school 124 (48.4) 122 (55.2) 246 (51.6)
Senior high school or above 95 (37.1) 65 (29.4) 160 (33.5)
Marital status
Married or living with partner 33 (12.8) 33 (14.9) 66 (13.8) 0.498
Single/divorced/widowed 225 (87.2) 188 (85.1) 413 (86.2)
Self-rated health status < 0.001
Poor/very poor 19 (7.4) 59 (26.7) 78 (16.3)
Fair/good/very good 239 (92.6) 162 (73.3) 401 (83.7)
Current crime type
Drug crime 219 (84.9) 189 (85.5) 408 (85.2) 0.845
Others 39 (15.1) 32 (14.5) 71 (14.8)
Recidivist
Yes 177 (68.6) 174 (78.7) 351 (73.3) 0.013
No 81 (31.4) 47 (21.3) 128 (26.7)
Use of illicit drugs
Yes 253 (98.1) 217 (98.2) 470 (98.1) 0.918
No 5 (1.9) 4 (1.8) 9 (1.9)
Notification of HIV infection 
after January 1, 2005†
Yes 207 (87.3) 154 (73.3) 361 (80.8) < 0.001
No 30 (12.7) 56 (26.7) 86 (19.2)
Mean age 33.8 ± 7.7 34.7 ± 7.5 34.2 ± 7.6 0.189
*Data presented as n (%) or mean ± standard deviation; †missing cases were deleted. BSRS-5 = Brief Symptom Rating Scale-5.
been notified of HIV infection prior to January
2005, and have poor self-rated health status.
Prevalence of psychiatric morbidity
As illustrated in Table 2, the prevalence of psychi-
atric morbidity was 46.1%. The mean scores of
each BSRS-5 item were significantly different be-
tween the BSRS-5 defined cases and their counter-
parts, with the highest mean scores for sleep
disturbance (1.56), followed by those with de-
pression (1.24). The prevalence of each BSRS-5
item, i.e. combining the percentage of “Quite a
bit” and “Extremely” responses (BSRS-5 ≥ 3), in
the BSRS-5 defined case group was: sleep distur-
bance (46.6%), depression (31.2%), inferiority
(24.0%), anxiety (21.2%), and hostility (21.2%).
In comparison, 3.9% of the non-case group had
a sleep disturbance, and none had any symptoms
of the BSRS-5, i.e. did not have a BSRS-5 ≥ 3.
Factors associated with psychiatric morbidity
As shown in Table 3, all lifetime experiences of
psychiatric symptoms (e.g. a lot of physical pain
or discomfort, serious depression for ≥ 2 weeks,
serious anxiety or tension, hallucinations, trouble
understanding/concentrating/remembering, trou-
ble controlling violent behavior, serious thoughts
of suicide, and attempts at suicide) were signifi-
cantly correlated with psychiatric morbidity.
Multivariate analysis of factors associated with
BSRS-5 defined cases is shown in Table 4. Partici-
pants were more likely to be BSRS-5 defined cases
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Table 2. Bivariate analysis of Brief Symptom Rating Scale items*
BSRS Item (score range)
BSRS-5 score
< 6 ≥ 6 Total
p
Number of participants 258 (53.9) 221 (46.1) 479 (100)
1. Trouble falling asleep/sleep 10 (3.9) 103 (46.6) 113 (23.6)
disturbance (0–4) 0.77 ± 0.78 2.48 ± 1.01 1.56 ± 1.23 < 0.001
2. Feeling tense or “keyed 0 47 (21.2) 47 (9.8)
up”/anxiety (0–4) 0.36 ± 0.50 1.86 ± 0.99 1.05 ± 1.07 < 0.001
3. Feeling easily annoyed or 0 47 (21.2) 47 (9.8)
irritated/hostility (0–4) 0.45 ± 0.51 1.84 ± 0.93 1.09 ± 1.01 < 0.001
4. Feeling blue/depression 0 69 (31.2) 69 (14.4)
(0–4) 0.47 ± 0.53 2.14 ± 0.96 1.24 ± 1.13 < 0.001
5. Feeling inferior to 0 53 (24.0) 53 (11.1)
others/inferiority (0–4) 0.30 ± 0.49 1.81 ± 1.17 1.00 ± 1.15 < 0.001
*Data presented as n (%) and mean ± standard deviation, The percentages indicate prevalence of “Quite a bit” (score 3) or “Extremely”
(score 4). BSRS-5 = Brief Symptom Rating Scale-5.
Table 3. Participants’ psychological statuses by Brief Symptom Rating Scale-5 score*
Variable
BSRS-5 score
< 6 ≥ 6
Total p
Serious of physical pain or discomfort
Yes 53 (20.5) 91 (41.2) 144 (30.1) < 0.001
No 205 (79.5) 130 (58.8) 335 (69.9)
Depression for ≥ 2 wk
Yes 33 (12.8) 81 (36.7) 114 (23.8) < 0.001
No 225 (87.2) 140 (63.3) 365 (76.2)
Serious anxiety or tension
Yes 23 (8.9) 79 (35.7) 102 (21.3) < 0.001
No 235 (91.1) 142 (64.3) 377 (78.7)
Hallucinations
Yes 7 (2.7) 31 (14.0) 38 (7.9) < 0.001
No 251 (97.3) 190 (86.0) 441 (92.1)
Trouble understanding, 
concentrating, or remembering
Yes 56 (21.7) 99 (44.8) 155 (32.4) < 0.001
No 202 (78.3) 122 (55.2) 324 (67.6)
Trouble controlling violent behavior
Yes 7 (2.7) 17 (7.7) 24 (5.0) 0.013
No 251 (97.3) 204 (92.3) 455 (95.0)
Serious thoughts of suicide 
Yes 6 (2.3) 51 (23.1) 57 (11.9) < 0.001
No 252 (97.7) 170 (76.9) 422 (88.1)
Attempted suicide 
Yes 2 (0.8) 18 (8.1) 20 (4.2) < 0.001
No 256 (99.2) 203 (91.9) 459 (95.8)
*Data presented as n (%). BSRS-5 = Brief Symptom Rating Scale-5.
than their counterparts if they were recidivists
(OR = 2.04), were in poor/very poor health sta-
tus (OR = 2.04), and in addition, if they reported
having experienced substantial physical pain or
discomfort (OR = 2.39), depression for ≥ 2 weeks
(OR=1.86), serious anxiety or tension (OR=4.05),
trouble understanding, concentrating or remem-
bering (OR = 2.36), or serious thoughts of suicide
(OR = 6.39), with a Nagelkerke R2 equal to 0.365.
Discussion
The prevalence of psychiatric morbidity was much
higher in the study sample (46.1%) than that re-
ported for the general population (8.8%).23
Notably, among the five symptoms measured by
the BSRS-5, the most prevalent was insomnia
(46.6%), followed by depression (31.3%). In-
somnia (3.9%) was also the only symptom preva-
lent among the non-cases group. This may be
partly due to the uncomfortable incarceration en-
vironment as well as the co-occurring psychiatric
symptoms, e.g. depression.
Many factors must be taken into considera-
tion when dealing with prisoners and mental
health, e.g. international differences, prison set-
tings, demographics and methodological issues.24
All inmates (including injection drug users) are
screened for HIV upon incarceration in Taiwan.
Individuals found to be seropositive are sepa-
rated from HIV seronegative prisoners. What 
impact such segregation has on inmates’ psycho-
logical well-being has not yet been determined.
However, it is reasonable to argue such separa-
tion, though effective in the prevention of HIV
transmission among inmates, is a form of stigma-
tization, and can be an additional stressor for
HIV-positive prisoners.
Previous research has shown that HIV-related
stigma can have a strong negative impact on 
individual social support, physical health, and
psychological well-being.25,26 Gonzalez et al27
also found a significant interaction between the
awareness of HIV/AIDS-related stigma and anxi-
ety symptoms. Future research is needed to further
assess the impact of stigma on inmate mental
health.
Furthermore, inmates who had used drugs ex-
hibit more health problems and greater rates of
chronic health problems than prisoners who have
not used drugs.28 As 98.1% of inmates in this
survey admitted using illicit drugs, this is a criti-
cal warning sign. The relationship between drug
use, mental disorders, and HIV infection clearly
merits further study.
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Table 4. Factors associated with Brief Symptom Rating Scale-5 defined cases following multivariate analysis*
Variable
Odds ratio (95% 
p
confidence interval)
Recidivism 2.04 (1.20–3.47) 0.009
Notification of HIV infection after 0.60 (0.34–1.07) 0.082
January 1, 2005
Poor/very poor self-rated health status 2.04 (1.06–3.95) 0.034
Serious physical pain or discomfort 2.39 (1.46–3.92) 0.001
Depression for ≥ 2 weeks 1.86 (1.05–3.29) 0.034
Serious anxiety or tension 4.05 (2.16–7.59) < 0.001
Hallucinations 1.31 (0.43–3.96) 0.633
Trouble understanding, concentrating, 2.36 (1.46–3.81) < 0.001
or remembering
Trouble controlling violent behavior 1.00 (0.28–3.52) 0.997
Serious thoughts of suicide 6.69 (2.38–18.82) < 0.001
Attempted suicide 4.04 (0.63–25.91) 0.141
*All the reference groups were those without the stated characteristic.
Of the inmates who were in the BSRS-5 defined
case group (n = 221), 23.1% had serious thoughts
of suicide and 8.1% had once attempted suicide,
perhaps due to the combined negative impact of
imprisonment and HIV-related physical and men-
tal health problems. Furthermore, as indicated 
in the multivariate analysis (Table 4), suicidal
ideation (OR = 6.69) was the strongest predictor
of the BSRS-5 defined cases. In other words, after
controlling for other variables, those with suici-
dal ideation were 6.69 times more likely to be
BSRS-5 defined psychiatric cases than their coun-
terparts. As previously reported, BSRS-5 could be
used as a suicide ideation screening instrument.21
Lifetime prevalence of serious anxiety or tension
(OR = 4.05) was also noted as another strong
predictor of the BSRS-5 defined cases. This may
also be, in part, due to their incarceration status.
Given that people living with HIV are aging,29 new
challenges will arise in the future for those mental
health professionals working with incarcerated.
There are several limitations to this study. First,
a cross-sectional analysis prevents us from making
causal inferences in predicting psychiatric morbid-
ity. Second, the BSRS-5 defined psychiatric mor-
bidity is important for screening but it does not
allow us to make diagnostic classifications. Third,
this study is based on self-reported data. Recall
bias and related factors may affect measurement,
although the use of anonymous questionnaires
may have minimized the risk of deliberated mis-
reporting. Finally, this study only focused on HIV-
infected adult male inmates and therefore lacks
the generalizability to reflect female HIV-infected
adult inmates, who have been reported to be quite
different.30,31 Despite these limitations, to the best
of our knowledge, this study is the first to use 
extensive samples from various geographic areas
to explore the psychiatric morbidity among HIV-
infected male inmates in Taiwan.
In conclusion, psychiatric morbidity is preva-
lent among HIV-infected male prisoners. The pres-
ent study identified multiple psychosocial factors
associated with psychiatric morbidity among HIV-
positive inmates in Taiwan. Being a recidivist,
having a poor self-rated health status, and having
experienced certain psychiatric symptoms in one’s
lifetime were significantly correlated to a partici-
pant’s psychiatric morbidity. It is suggested that
tailored HIV/AIDS education related to mental
health should be included as part of the compre-
hensive HIV/AIDS training program for those
treating incarcerated populations.
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